GlassScriptPhysician profile
Laura A King
NPI 1487623948
$2,341.67
in general payments reported to CMS, 2019-2025
23 companies · $361 in 2025
The $361 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $116 · 2021: $162 · 2022: $341 · 2023: $246 · 2024: $463 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $398.11 | 2019-2023 | |
| Amgen INC. | $393.33 | 2020-2024 | Otezla |
| Leo Pharma INC. | $230.09 | 2019-2025 | Anzupgo |
| Novartis Pharmaceuticals Corporation | $225.45 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $172.37 | 2022-2023 | Dupixent |
| Pfizer INC. | $164.44 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $147.37 | 2023-2025 | Sotyktu |
| Genzyme Corporation | $143.72 | 2025 | |
| Galderma Laboratories, L.P. | $82.69 | 2019-2024 | |
| Incyte Corporation | $45.40 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $43.35 | 2019 | |
| Lilly USA, LLC | $37.50 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $34.22 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.04 | 2019 | |
| Ucb, INC. | $26.59 | 2025 | Bimzelx |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $26.30 | 2020 | |
| Celgene Corporation | $22.94 | 2019 | |
| Allergan, INC. | $22.92 | 2021 | |
| Revance Therapeutics, INC. | $20.37 | 2024 | Daxxify |
| Genentech USA, INC. | $19.71 | 2021 | |
| Organon LLC | $18.68 | 2024 | |
| Prugen, INC. Pharmaceuticals | $18.11 | 2020 | |
| Dermavant Sciences, INC. | $17.97 | 2023 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.